Search Results 31-40 of 16454 for ������������KA���:ZA31���24������ ���������������������������������
Rochester, Minn. You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.
All treated subjects will be evaluated at procedure, 3-months, 6-months (phone), 12-months, 18-months (phone), and 24-months post-procedure. The primary ...
2025 Apr 24; 15 (1):14399. View PubMed; Garmany A ... KA, Whelan ER, Kocsis SPC, Edenfield BH, Walker ... 2022 Feb 22; 16 (2):2741-2755 Epub 2022 Jan 24
Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
Overview. Tab Title Description. Study IDs. Study IDs. Site IRB. Jacksonville, Florida: 24-005545; Rochester, Minnesota: 24-005545. About this study. The ...
Nath KA, Garovic VD, Grande JP, Croatt AJ ... 2011 Mar; 300(3):H718-24. Epub 2010 Dec 10. View ... Katusic ZS, d'Uscio LV, Nath KA. Vascular ...
Rochester, Minnesota: 24-013778. Sponsor Protocol Number: 24-013. About this study. The purpose of this study is to investigate if DNA cancer-associated ...
2013 Sep; 40(3):509-24. Epub 2013 Jul 17. View PubMed; Weiss KE, Hahn A, Wallace DP, Biggs B, Bruce BK, Harrison TE. Acceptance of pain: associations with ...
... 24 hrs (6 yrs) 52 mg intrauterine device,959.24 636000003,50419042401,levonorgestreL 17.5 mcg/24 hrs (5yrs) 19.5mg intrauterine device,"1,907.02 ...
... 24 hours on the serial computed tomographic (CT) scans. Assess the safety of the intensive treatment relative to the standard treatment in the proportion of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.